Your browser doesn't support javascript.
loading
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
Stockman, David L; Curry, Jonathan L; Torres-Cabala, Carlos A; Watson, Ian R; Siroy, Alan E; Bassett, Roland L; Zou, Lihua; Patel, Keyur P; Luthra, Rajyalakshmi; Davies, Michael A; Wargo, Jennifer A; Routbort, Mark A; Broaddus, Russell R; Prieto, Victor G; Lazar, Alexander J; Tetzlaff, Michael T.
Affiliation
  • Stockman DL; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Curry JL; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Torres-Cabala CA; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Watson IR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Siroy AE; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bassett RL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zou L; The Eli and Edythe L. Broad Institute of Massachusetts, Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Patel KP; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Luthra R; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wargo JA; Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Routbort MA; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Broaddus RR; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Prieto VG; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lazar AJ; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tetzlaff MT; Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Cutan Pathol ; 42(5): 308-17, 2015 May.
Article in En | MEDLINE | ID: mdl-25754356
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Chromosomal Proteins, Non-Histone / Sequence Analysis, DNA / DNA-Binding Proteins / High-Throughput Nucleotide Sequencing / Melanoma / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Cutan Pathol Year: 2015 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Chromosomal Proteins, Non-Histone / Sequence Analysis, DNA / DNA-Binding Proteins / High-Throughput Nucleotide Sequencing / Melanoma / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Cutan Pathol Year: 2015 Type: Article Affiliation country: United States